CD40 and neoplasm: For example, Cho and Celis have demonstrated that a vaccination approach using synthetic peptides representing CTL epitopes, TLR agonists and anti-CD40 antibodies was able to generate large quantities of high-avidity antigen-reactive T cells capable of killing tumor cells [45].